1Chang K, Ding I, Kern FG, et al. Immunohistochemical analysis of P53 and erb B-2/neu proteins in human turmor[J]. J Histochern cytochern, 1991,39 : 1 :1281.
2Fujimoto K, Yamada Y, okajima E, et al. Frequent association of P53 gene mutation in invasive bladder cancer[J]. Cancer Re.s, 1992,52 : 1393.
3Urderwood MA, Reeves J, Smith G, et al. Overexpression of P53 protein and its significance for recurrent progressive bladder tumours[J]. BrJ Urol, 1996,56(2): 69.
4Hong RL, Ru YS, Chu JS, et al. Correlation of expression CD44 isoforms and E cadherin with differentiation in human wrothelial cell lines and transitional cell carcinoma[J]. Cancer Lett , 1995,89:81.
5Southgate J, Trejdosiewicz LK, Smith B, et al. Patterns of splice variant CD44 expression by normal human urothelium in situ and in vitro and by bladder-carcinoma cell lines[J]. Int J Cancer, 1995,65:449.
6Porter PL, Gown AM, Kramp SG, et al. Widespread P53 over expression in human malignant tumors[J]. Am J Pathol,1992,140: 145.
7Isaas WB, Garter BS, Ewing CM. Wild type P53 Suppreses growth of human prostate Carcinoma[J]. Cancer Res, 1991,51:4716.
8IggoR, Garter K, Bartek J, et al. Increased expression of murant forms of P53 oncogene in primary lung canecr[J]. Lancet,1990,335:675.
9Lipponet PK. Over-expression of P53 nuclear oncoprotein in treansitional-cell blader and cancer and its prognostic value[J]. Int J Cancer,1993,53:365.
10Wright C, Mellon K, Johnston P, et al. Expression of mutant P53, C erb B-2 and the epidermal growth factor receptor in transitional cell carcinoma of the numan urinary bladder[J].Int J Cancer,1991,63:967.
